Acquisitions - Schedule of Consideration Transferred and Allocation to Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	May 06, 2024	Dec. 31, 2022	Dec. 31, 2021
Consideration Transferred:
Cash paid		$ 1,648.8	$ 242.6
Cash acquired		(52.6)	(22.9)
Holdback			1.2
Fair value of hybrid financial instruments - founders			36.1
Fair value of redeemable noncontrolling interest - other shareholders			12.6
Fair value of contingent consideration		13.4	2.9
Working capital and other closing adjustments		26.2
Total consideration transferred, net of cash acquired		137.7	96.3
Allocation of Consideration Transferred:
Accounts receivable		58.3	11.1
Inventories		147.9	45.0
Other current assets		29.1	10.6
Property, plant and equipment		70.4	42.1
Deferred tax assets			182.7
Other assets		91.4	32.9
Goodwill		1,507.3	582.6		$ 457.6	$ 339.5
Deferred taxes (net)		(113.2)
Liabilities assumed		(307.5)	(119.5)
Total consideration allocated		1,635.8	416.6
Bargain purchase gain			$ 144.1
Business Combination, Bargain Purchase, Gain, Statement of Income or Comprehensive Income [Extensible Enumeration]			Business Combination Bargain Purchase Adjustment Gain Loss
Operating segments
Consideration Transferred:
Total consideration transferred, net of cash acquired		1,635.8	$ 272.5
Allocation of Consideration Transferred:
Goodwill		958.3	114.2
Technology
Allocation of Consideration Transferred:
Intangible assets		316.8	61.8
Customer relationships
Allocation of Consideration Transferred:
Intangible assets		335.3	29.3
Backlog
Allocation of Consideration Transferred:
Intangible assets		14.8	1.0
Trade name
Allocation of Consideration Transferred:
Intangible assets		34.2	5.4
Nanostring Technologies
Consideration Transferred:
Cash paid		392.6
Cash acquired		(0.5)
Fair value of contingent consideration		0.0
Working capital and other closing adjustments		0.0
Total consideration transferred, net of cash acquired		392.1
Allocation of Consideration Transferred:
Accounts receivable		16.8
Inventories		38.5
Other current assets		8.9
Property, plant and equipment		31.0
Other assets		23.1
Goodwill		253.8
Deferred taxes (net)		4.8
Liabilities assumed		(90.8)		$ (44.7)
Total consideration allocated		392.1
Nanostring Technologies | Technology
Allocation of Consideration Transferred:
Intangible assets		53.0
Nanostring Technologies | Customer relationships
Allocation of Consideration Transferred:
Intangible assets		39.0
Nanostring Technologies | Backlog
Allocation of Consideration Transferred:
Intangible assets		0.0
Nanostring Technologies | Trade name
Allocation of Consideration Transferred:
Intangible assets		14.0
ELITechGroup
Consideration Transferred:
Cash paid		951.9
Cash acquired		(43.4)
Fair value of contingent consideration		0.0
Working capital and other closing adjustments		22.7
Total consideration transferred, net of cash acquired		931.2
Allocation of Consideration Transferred:
Accounts receivable		30.6
Inventories		31.6
Other current assets		15.7
Property, plant and equipment		36.2
Other assets		41.3
Goodwill		501.1
Deferred taxes (net)		(100.8)
Liabilities assumed		(66.9)
Total consideration allocated		931.2
ELITechGroup | Technology
Allocation of Consideration Transferred:
Intangible assets		193.3
ELITechGroup | Customer relationships
Allocation of Consideration Transferred:
Intangible assets		236.3
ELITechGroup | Backlog
Allocation of Consideration Transferred:
Intangible assets		0.5
ELITechGroup | Trade name
Allocation of Consideration Transferred:
Intangible assets		12.3
Chemspeed Technologies A G
Consideration Transferred:
Cash paid		175.4
Cash acquired		(0.6)
Fair value of contingent consideration		0.0
Working capital and other closing adjustments		0.0
Total consideration transferred, net of cash acquired		174.8
Allocation of Consideration Transferred:
Accounts receivable		7.0
Inventories		46.6
Other current assets		1.4
Property, plant and equipment		1.8
Other assets		17.3
Goodwill		127.8
Deferred taxes (net)		(14.0)
Liabilities assumed		(106.7)
Total consideration allocated		174.8
Chemspeed Technologies A G | Technology
Allocation of Consideration Transferred:
Intangible assets		27.9
Chemspeed Technologies A G | Customer relationships
Allocation of Consideration Transferred:
Intangible assets		51.5
Chemspeed Technologies A G | Backlog
Allocation of Consideration Transferred:
Intangible assets		9.4
Chemspeed Technologies A G | Trade name
Allocation of Consideration Transferred:
Intangible assets		4.8
Other
Consideration Transferred:
Cash paid		128.9	47.8
Cash acquired		(8.1)	(1.6)
Holdback			1.0
Fair value of hybrid financial instruments - founders			36.1
Fair value of redeemable noncontrolling interest - other shareholders			10.1
Fair value of contingent consideration		13.4	2.9
Working capital and other closing adjustments		3.5
Total consideration transferred, net of cash acquired		137.7	96.3
Allocation of Consideration Transferred:
Accounts receivable		3.9	1.9
Inventories		31.2	2.5
Other current assets		3.1	2.1
Property, plant and equipment		1.4	0.6
Deferred tax assets			0.0
Other assets		9.7	4.3
Goodwill		75.6	66.7
Deferred taxes (net)		(3.2)
Liabilities assumed		(43.1)	(19.8)
Total consideration allocated		137.7	96.3
Bargain purchase gain			0.0
Other | Technology
Allocation of Consideration Transferred:
Intangible assets		42.6	27.6
Other | Customer relationships
Allocation of Consideration Transferred:
Intangible assets		8.5	7.5
Other | Backlog
Allocation of Consideration Transferred:
Intangible assets		4.9	0.2
Other | Trade name
Allocation of Consideration Transferred:
Intangible assets		$ 3.1	2.7
Biognosys, Ag
Consideration Transferred:
Cash paid			73.6
Cash acquired			(9.5)
Holdback			0.2
Fair value of hybrid financial instruments - founders			0.0
Fair value of redeemable noncontrolling interest - other shareholders			2.5
Fair value of contingent consideration			0.0
Total consideration transferred, net of cash acquired			66.8
Allocation of Consideration Transferred:
Accounts receivable			3.6
Inventories			0.4
Other current assets			0.9
Property, plant and equipment			8.0
Deferred tax assets			0.0
Other assets			4.3
Goodwill			47.5
Liabilities assumed			(25.4)
Total consideration allocated			66.8
Bargain purchase gain			0.0
Biognosys, Ag | Technology
Allocation of Consideration Transferred:
Intangible assets			10.2
Biognosys, Ag | Customer relationships
Allocation of Consideration Transferred:
Intangible assets			13.8
Biognosys, Ag | Backlog
Allocation of Consideration Transferred:
Intangible assets			0.8
Biognosys, Ag | Trade name
Allocation of Consideration Transferred:
Intangible assets			2.7
PhenomeX, Inc.
Consideration Transferred:
Cash paid	[1]		121.2
Cash acquired			(11.8)
Holdback			0.0
Fair value of hybrid financial instruments - founders			0.0
Fair value of redeemable noncontrolling interest - other shareholders			0.0
Fair value of contingent consideration			0.0
Total consideration transferred, net of cash acquired			109.4
Allocation of Consideration Transferred:
Accounts receivable			5.6
Inventories			42.1
Other current assets			7.6
Property, plant and equipment			33.5
Deferred tax assets			182.7
Other assets			24.3
Goodwill			0.0
Liabilities assumed			(74.3)
Total consideration allocated			253.5
Bargain purchase gain			144.1
PhenomeX, Inc. | Technology
Allocation of Consideration Transferred:
Intangible assets			24.0
PhenomeX, Inc. | Customer relationships
Allocation of Consideration Transferred:
Intangible assets			8.0
PhenomeX, Inc. | Backlog
Allocation of Consideration Transferred:
Intangible assets			0.0
PhenomeX, Inc. | Trade name
Allocation of Consideration Transferred:
Intangible assets			$ 0.0

[1] Total cash consideration consisted of $107.2 million for the acquisition of the outstanding stock including an $8.0 million payment to settle an employee award, and settlement of a $14.0 million note previously issued by the Company to PhenomeX during 2023. (b) This amount includes an assumed liability for vested employee awards of $6.3 million on the acquisition date which was settled in the post-closing period ended March 31, 2023, for Biognosys, AG.